Previous Close | 5.90 |
Open | 8.50 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 35.00 |
Expire Date | 2025-01-17 |
Day's Range | 8.50 - 8.50 |
Contract Range | N/A |
Volume | |
Open Interest | N/A |
Emma Walmsley, chief executive officer of the pharmaceutical firm hailed a ‘strong start to 2024’.
Glaxo (GSK) delivered earnings and revenue surprises of 15.96% and 3.99%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
The latest investor updates on stocks that are trending on Wednesday.